(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.57%) $79.45
(1.24%) $1.956
(0.74%) $2 328.10
(0.18%) $26.80
(1.25%) $966.80
(0.03%) $0.933
(-0.01%) $11.03
(-0.06%) $0.798
(0.27%) $93.51
-0.04% € 75.49
Live Chart Being Loaded With Signals
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software...
Stats | |
---|---|
Tagesvolumen | 475.00 |
Durchschnittsvolumen | 973.00 |
Marktkapitalisierung | 100.24B |
EPS | €0.682 ( 2023-10-31 ) |
Last Dividend | €0.690 ( 2023-09-21 ) |
Next Dividend | €0 ( N/A ) |
P/E | 25.68 |
ATR14 | €0 (0.00%) |
Medtronic PLC Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Medtronic PLC Finanzdaten
Annual | 2022 |
Umsatz: | €31.23B |
Bruttogewinn: | €20.51B (65.67 %) |
EPS: | €2.83 |
FY | 2022 |
Umsatz: | €31.23B |
Bruttogewinn: | €20.51B (65.67 %) |
EPS: | €2.83 |
FY | 2022 |
Umsatz: | €31.69B |
Bruttogewinn: | €21.54B (67.98 %) |
EPS: | €3.75 |
FY | 2021 |
Umsatz: | €30.12B |
Bruttogewinn: | €19.63B (65.19 %) |
EPS: | €2.69 |
Financial Reports:
No articles found.
Medtronic PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0.680 (N/A) |
€0.680 (N/A) |
€0.680 (N/A) |
€0.690 (N/A) |
€0.690 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.320 | 2008-03-26 |
Last Dividend | €0.690 | 2023-09-21 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 58 | -- |
Total Paid Out | €24.44 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.01 | -- |
Div. Sustainability Score | 9.19 | |
Div.Growth Potential Score | 3.66 | |
Div. Directional Score | 6.43 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LUS1.DE | Ex Dividend Junior | 2023-06-23 | Annually | 0 | 0.00% | |
2M6.DE | Ex Dividend Knight | 2023-09-21 | Quarterly | 0 | 0.00% | |
VFP.DE | Ex Dividend Junior | 2023-09-08 | Quarterly | 0 | 0.00% | |
ENI.F | Ex Dividend Knight | 2023-11-20 | Semi-Annually | 0 | 0.00% | |
NVJP.DE | Ex Dividend Knight | 2023-08-18 | Annually | 0 | 0.00% | |
AHC.DE | Ex Dividend Knight | 2023-09-15 | Quarterly | 0 | 0.00% | |
GRM.DE | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% | |
PUM.DE | Ex Dividend Junior | 2023-05-25 | Annually | 0 | 0.00% | |
BMW.DE | Ex Dividend Junior | 2023-05-12 | Annually | 0 | 0.00% | |
INN1.DE | Ex Dividend Junior | 2023-08-07 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.130 | 1.500 | 7.40 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0462 | 1.200 | 8.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0816 | 1.500 | -0.204 | -0.307 | [0.1 - 1] |
payoutRatioTTM | 0.871 | -1.000 | 1.293 | -1.293 | [0 - 1] |
currentRatioTTM | 2.30 | 0.800 | 3.51 | 2.80 | [1 - 3] |
quickRatioTTM | 1.459 | 0.800 | 6.12 | 4.90 | [0.8 - 2.5] |
cashRatioTTM | 0.166 | 1.500 | -0.190 | -0.286 | [0.2 - 2] |
debtRatioTTM | 0.277 | -1.500 | 5.38 | -8.07 | [0 - 0.6] |
interestCoverageTTM | 8.05 | 1.000 | 8.13 | 8.13 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.15 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.486 | -1.500 | 8.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.655 | 1.000 | 2.42 | 2.42 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.175 | 1.000 | 8.50 | 8.50 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.257 | 1.000 | 9.68 | 9.68 | [0.2 - 2] |
assetTurnoverTTM | 0.356 | 0.800 | -0.961 | -0.769 | [0.5 - 2] |
Total Score | 9.19 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.47 | 1.000 | 7.53 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0816 | 2.50 | -0.131 | -0.307 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.76 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.43 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.871 | 1.500 | 1.293 | -1.293 | [0 - 1] |
pegRatioTTM | -0.974 | 1.500 | -9.83 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.200 | 1.000 | 7.50 | 0 | [0.1 - 0.5] |
Total Score | 3.66 |
Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.